You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)

Completed
  • Diffuse Cutaneous Systemic Sclerosis
  • Los Angeles, California
  • +4 more
Jan 5, 2023

Diffuse Cutaneous Systemic Sclerosis Trial in United States (TEPEZZA, Placebo)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • TEPEZZA
  • Placebo
  • Los Angeles, California
  • +6 more
Jul 22, 2022

Diffuse Cutaneous Systemic Sclerosis Trial (Brentuximab vedotin)

Not yet recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab vedotin
  • (no location specified)
Apr 11, 2022

Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc Trial in Canada, United States (Brentuximab Vedotin, Placebo)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • +2 more
  • Brentuximab Vedotin
  • Placebo
  • Los Angeles, California
  • +9 more
May 12, 2022

Systemic Sclerosis Trial in Worldwide (SAR156597, Placebo)

Completed
Has Results
  • Systemic Sclerosis
  • San Francisco, California
  • +43 more
Mar 10, 2022

Systemic Sclerosis, Scleroderma Trial in Ann Arbor, Pittsburgh (Tofacitinib, Placebo Oral Tablet)

Completed
Has Results
  • Systemic Sclerosis
  • Scleroderma
  • Ann Arbor, Michigan
  • +1 more
Apr 28, 2020

Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab Vedotin
  • London, Ontario, Canada
    Rheumatology Clinic, St. Joseph's Health Care
Feb 3, 2022

Diffuse Cutaneous Systemic Sclerosis Trial in Ann Arbor (FCR001)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • FCR001
  • Ann Arbor, Michigan
    University of Michigan
Mar 4, 2022

Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited Trial in India, United States (Oral Ifetroban, Oral Placebo)

Recruiting
  • Scleroderma, Diffuse
  • +7 more
  • Oral Ifetroban
  • Oral Placebo
  • Tucson, Arizona
  • +15 more
Jun 30, 2022

Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic Trial in New Orleans (HZN-825)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Sclerosis, Systemic
  • New Orleans, Louisiana
    DelRicht Clinical Research, LLC
Nov 15, 2022

Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • +3 more
  • (no location specified)
Nov 21, 2023

Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma Trial in Worldwide (Upfront autologous HSCT)

Recruiting
  • Systemic Sclerosis
  • +7 more
  • Upfront autologous HSCT
  • Ghent, Belgium
  • +13 more
Nov 25, 2021

Efficacy of Tofacitinib in the Systemic Sclerosis Trial in Dhaka (Tofacitinib)

Recruiting
  • Efficacy of Tofacitinib in the Systemic Sclerosis
  • Dhaka, Shahbag, Bangladesh
    Nabil Amin Khan
Sep 18, 2023

Scleroderma, Systemic Trial in Worldwide (BI 685509, Placebo)

Recruiting
  • Scleroderma, Systemic
  • BI 685509
  • Placebo
  • Liverpool, New South Wales, Australia
  • +25 more
Jan 27, 2023

Systemic Sclerosis, Limited Cutaneous Systemic Sclerosis Trial in United Kingdom (Mycophenolate Mofetil 500mg)

Recruiting
  • Systemic Sclerosis
  • Limited Cutaneous Systemic Sclerosis
  • Mycophenolate Mofetil 500mg
  • Cambridge, Choose County, United Kingdom
  • +13 more
Nov 4, 2022

Evaluation of Muscle Involvement in Systemic Sclerosis

Not yet recruiting
  • Systemic Sclerosis
  • muscle involvement
  • Nancy, France
    Paul Decker
Sep 21, 2023

Systemic Sclerosis, Malnutrition, Loss of Appetite Trial in Khon Kaen (CBD oil, Placebo)

Not yet recruiting
  • Systemic Sclerosis
  • +2 more
  • CBD oil
  • Placebo
  • Khon Kaen, Thailand
    Department of Medicine, Faculty of Medicine, Khon Kaen Universit
Nov 4, 2022

Systemic Sclerosis, Scleroderma, Diffuse Systemic Sclerosis Trial in Scottsdale (Ixazomib)

Recruiting
  • Systemic Sclerosis
  • +18 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
May 3, 2022

Patients Receiving MMF for Diffuse Cutaneous or Pulmonary

Recruiting
  • Systemic Sclerosis
  • AUC of MPA measure
  • Paris, France
    Cochin hospital, AP-HP
Nov 19, 2021

Systemic Sclerosis Trial (RY_SW01 cell injection, Basic treatment)

Not yet recruiting
  • Systemic Sclerosis
  • RY_SW01 cell injection
  • Basic treatment
  • (no location specified)
Sep 21, 2023

Systemic Sclerosis Trial in United Kingdom (Prednisolone 5 mg, Placebo oral capsule; From August 2020 'no additional treatment')

Completed
  • Systemic Sclerosis
  • Prednisolone 5 mg
  • Placebo oral capsule; From August 2020 'no additional treatment'
  • Aberdeen, Aberdeenshire, United Kingdom
  • +13 more
Jul 29, 2021

Hand Function Impairment in Systemic Sclerosis: Outcomes,

Not yet recruiting
  • Systemic Sclerosis
  • Imaging, blood samples, fuctional tests and physical examination
  • (no location specified)
Nov 15, 2023

Stem Cell Factor,Potential Biological Marker of Skin Involvement

Recruiting
  • Systemic Sclerosis
  • ELISA
  • Videocapillaroscopy
  • Brussels, Belgium
    CHU Brugmann
Jul 29, 2022

PortoSinusoidal Vascular Diseases and Systemic Sclerosis

Recruiting
  • PSVD With or Without SSc
    • Caen, Calvados, France
      Chu de Caen
    Sep 5, 2023

    Diffuse Infiltrating Pneumonia Associated With Systemic

    Recruiting
    • Systemic Sclerosis
    • lung function tests
    • Lille, France
    • +1 more
    Jan 17, 2023